CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 101 filers reported holding CYTOKINETICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,504,000 | +33.5% | 123,763 | +0.8% | 0.00% | +100.0% |
| Q3 2016 | $1,127,000 | -2.4% | 122,815 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $1,155,000 | +32.5% | 121,700 | -1.6% | 0.00% | 0.0% |
| Q1 2016 | $872,000 | -31.7% | 123,630 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $1,277,000 | +2.7% | 122,128 | -34.3% | 0.00% | 0.0% |
| Q3 2015 | $1,243,000 | +6.0% | 185,783 | +6.4% | 0.00% | 0.0% |
| Q2 2015 | $1,173,000 | -29.0% | 174,596 | -28.3% | 0.00% | -50.0% |
| Q1 2015 | $1,651,000 | -16.2% | 243,562 | -0.9% | 0.00% | 0.0% |
| Q4 2014 | $1,969,000 | +124.3% | 245,868 | -1.4% | 0.00% | +100.0% |
| Q3 2014 | $878,000 | -25.9% | 249,439 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $1,185,000 | -55.3% | 247,866 | -11.2% | 0.00% | -66.7% |
| Q1 2014 | $2,653,000 | +42.4% | 279,229 | -2.6% | 0.00% | +50.0% |
| Q4 2013 | $1,863,000 | +1344.2% | 286,559 | +1579.9% | 0.00% | – |
| Q3 2013 | $129,000 | – | 17,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |